A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen [...]
Posted in Anti-counterfeiting, Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain, compliance | Also tagged Institute of Medicine, National Institute of Standards and Technology, NIST, Public health, Supply Chain
PharmExec Blog
Follow Us
RSS
Bookstore
IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"